47.73.Z - Retail sale of pharmaceutical products
21.10.Z - Manufacture of basic pharmaceutical products
21.20.Z - Manufacture of pharmaceutical preparations and other pharmaceutical products
47.74.Z - Retail sale of medical and orthopedic products
47.75.Z - Retail sale of cosmetics and toiletries
47.91.Z - Intermediary retail sale, non-specialized
62.03.Z - Activities related to programming, IT consulting, and related activities
68.10.Z - Real estate activities on own account and development of building projects
68.20.Z - Rental and management of own or leased real estate
73.11.Z - Advertising agency activities
2022 | 2023 | ||
---|---|---|---|
M PLN | M PLN | % | |
Gross profit (loss) | 3,5 | 3,8 | 7,2 |
EBITDA | 3,7 | 3,9 | 6,6 |
Short time liabilities | 6,1 | 7,2 | 19,1 |
Equity capital | 3,6 | 3,8 | 7,2 |
Operating profit (EBIT) | 3,6 | 3,8 | 6,7 |
Assets | 9,6 | 11 | 14,7 |
Net profit (loss) | 3,5 | 3,8 | 7,2 |
Cash | 1,4 | 1,4 | 1,1 |
Liabilities and provisions for liabilities | 6,1 | 7,2 | 19,1 |
Net income from sale | 51,2 | 56,2 | 9,7 |
Working assets | 7,5 | 9 | 20,4 |
Depreciation | 0,1 | 0,1 | 1,9 |
% | % | p.p. | |
Profitability of capital | 99,8 | 99,8 | 0 |
Equity capital to total assets | 36,9 | 34,5 | -2,4 |
Gross profit margin | 6,9 | 6,8 | -0,1 |
EBITDA Margin | 7,2 | 7 | -0,2 |
Days | Days | Days | |
Short term commitment turnover cycle | 43 | 47 | 4 |
Opinie dotyczące usług, produktów oraz działalności firmy nie są weryfikowane